When the COVID-19 pandemic hit in early 2020, 50-year-old Regina Paritsky, MEd, found a silver lining in the stay-at-home orders. She had been diagnosed with ulcerative colitis two years earlier, and despite close management by her gastroenterologist, Gary Lichtenstein, MD, she still did not have her disease under control.
“I had started on Entyvio [vedolizumab, Takeda] in the fall of 2018, and did OK on that for about a year, but beginning in late 2019, I’d started having symptoms